Barinthus Biotherapeutics (BRNS) Shareholder's Equity Growth (3y) (2023 - 2026)
Barinthus Biotherapeutics (BRNS) Shareholder's Equity Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.25% |
| Dec 31, 2025 | -32.68% |
| Sep 30, 2025 | -29.77% |
| Jun 30, 2025 | -26.18% |
| Mar 31, 2025 | -22.99% |
| Dec 31, 2024 | -19.83% |
| Sep 30, 2024 | -13.04% |
| Jun 30, 2024 | -14.39% |
| Mar 31, 2024 | 73.87% |
| Dec 31, 2023 | 91.89% |
| Sep 30, 2023 | 106.35% |
| Jun 30, 2023 | 111.32% |
| Mar 31, 2023 | 122.62% |